Silver Book Fact

A 10 percent reduction in cancer-related deaths in the U.S. would be worth an estimated $4.4 trillion to current and future generations.

Murphy, Kevin M. and Robert H. Topel. Measuring the Gains from Medical Research: An economic approach. Chicago, IL: The University of Chicago Press; 2003

Reference

Title
Measuring the Gains from Medical Research: An economic approach
Publisher
The University of Chicago Press
Publication Date
2003
Authors
Murphy, Kevin M. and Robert H. Topel

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Widespread use of selective estrogen receptor modulators could result in an approximately 30% decrease in breast cancer.  
  • Investments in cancer research and development between 1998 and 2000 has generated 23 million additional healthy years of life and $1.9 trillion of additional social value.  
  • From 2007 to 2011, lung cancer incidence rates decreased by three percent each year in men and 2.2 percent each year in women.  
  • Medicines Prevent Cancer Recurrence: New breast cancer drug greatly reduces recurrence and death (5 to 10 years after diagnosis in postmenopausal women)  
  • Five-year Relative Survival (%) during Three Time Periods by Cancer Site